Search Results - "Spigelman, Mel"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects by GINSBERG, Ann M, LAURENZI, Martino W, ROUSE, Doris J, WHITNEY, Karl D, SPIGELMAN, Mel K

    Published in Antimicrobial Agents and Chemotherapy (01-09-2009)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    New drugs for tuberculosis: current status and future prospects by O'Brien, Richard J, Spigelman, Mel

    Published in Clinics in chest medicine (01-06-2005)
    “…This article reviews two classes of compounds that have advanced into phase II and III clinical trials, long-acting rifamycins and fluoroquinolones, and a…”
    Get more information
    Journal Article
  3. 3

    New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future by Lienhardt, Christian, Raviglione, Mario, Spigelman, Mel, Hafner, Richard, Jaramillo, Ernesto, Hoelscher, Michael, Zumla, Alimuddin, Gheuens, Jan

    Published in The Journal of infectious diseases (15-05-2012)
    “…For the first time in 40 years, a portfolio of promising new compounds for the treatment of tuberculosis is on the horizon. The introduction of new drugs in…”
    Get full text
    Journal Article
  4. 4

    Collaborations between product development partnerships and the World Health Organization by Helble, Matthias, Kuchenmüller, Tanja, Reeder, John, Kim, Jerome H, Pécoul, Bernard, Reddy, David, Spigelman, Mel, Swaminathan, Soumya

    Published in Bulletin of the World Health Organization (01-05-2023)
    “…Over the last two decades, product development partnerships have proven to be a successful model of public-private partnership. Product development…”
    Get full text
    Journal Article
  5. 5

    An Exposure-Response Perspective on the Clinical Dose of Pretomanid by Nedelman, Jerry R, Salinger, David H, Subramoney, Vishak, Woolson, Rob, Wade, Karen, Li, Mengchun, Everitt, Daniel, Mendel, Carl M, Spigelman, Mel

    Published in Antimicrobial agents and chemotherapy (16-12-2020)
    “…Pretomanid was approved by the U.S. FDA, via the limited population pathway for antibacterial and antifungal drugs, as part of a three-drug regimen with…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Multidrug-Resistant Tuberculosis by D'Ambrosio, Lia, Centis, Rosella, Migliori, Giovanni B, Chai, Shua J, Rao, Carol Y, Varma, Jay K, Spigelman, Mel, Compton, Carolyn, Gheuens, Jan, Chaisson, Richard E, Nuermberger, Eric L

    Published in The New England journal of medicine (29-11-2012)
    “…To the Editor: The study by Gler et al. (June 7 issue) 1 provides a needed reminder regarding the development pipeline for drugs for tuberculosis and…”
    Get full text
    Journal Article
  10. 10